VPT
Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”) (TSXV:VPT) (OTC:VPTDF), is pleased to announce that is has entered into an agreement with Leede Jones Gable Inc. and Stifel GMP as the underwriters and co-bookrunners (the “Underwriters”), pursuant to which the Underwriters…...
September 15, 2021
Ventripoint Provides Update on Clinical Studies
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has provided an update on clinical studies using the VMS+ 3.0.Ventripoint Overview: A Revolutionary Way to View and Analyze the HeartVentripoint is an industry leader in the application of ultrasound AI…...
September 14, 2021
Ventripoint Provides Update on Growth Initiatives and Sales
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) has provided an update on recent milestones including sales, marketing, COVID-19-related developments and market outreach....
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it has filed its interim unaudited Financial Statements and Management Discussion and Analysis (MD&A) for the second quarter, ending June 30, 2021. These filings can be…...
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has filed an international patent application under the Patent Cooperation Treaty (PCT) to protect Ventripoint’s recent novel improvements to its cardiac measurement technology. Ventripoint is a pioneer in application of artificial…...
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that they will be a Bronze level sponsor for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology (AEPC) to be held digitally…...
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to provide this update on its financial status and the exercises of warrants and options since the last update (see NR March 3, 2021).Since the last update, the Company…...
May 4, 2021
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is excited to announce that it is receiving advisory services and research and development funding of up to $120,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC…...
April 27, 2021
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) announces the Company has entered into a collaboration with GE Healthcare.Ventripoint has been added as an innovator under GE Healthcare’s Edison Developer Program, which helps healthcare providers gain access to market-ready…...
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) attended the 23rd Annual Canadian Echo Weekend – 2021 Digital Edition, which was organized by the Canadian Society of Echocardiography (CSE).Ventripoint participated as a sponsor for this year’s conference and received…...